Blood Glucose Monitoring Frequency in NPO Patients
Standard Monitoring Protocol
- The American Diabetes Association recommends checking blood glucose every 4-6 hours while the patient remains NPO, as this is the explicit recommendation from the American Diabetes Association Standards of Care 1, 2, 3
- This frequency applies to noncritically ill patients who are not eating and receiving basal insulin or basal-plus-correction insulin regimens, according to the American Diabetes Association 1
- Point-of-care (POC) capillary glucose monitoring should be used for these measurements, as recommended by the American Diabetes Association 2, 3
Special Circumstances Requiring More Frequent Monitoring
- Patients receiving continuous intravenous insulin infusion should be monitored every 30 minutes to 2 hours, as recommended by the American Diabetes Association 1, 2, 3
- The American Diabetes Association recommends maintaining blood glucose between 100-180 mg/dL for most noncritically ill NPO patients 2
- For critically ill patients, the American Diabetes Association recommends targeting 140-180 mg/dL 2, 3
Clinical Context and Rationale
- The 4-6 hour monitoring interval for NPO patients allows for timely adjustment of correction insulin doses based on glucose trends, as recommended by the American Diabetes Association 1
- The American Diabetes Association recommends not relying solely on sliding-scale correction insulin without scheduled basal insulin coverage in NPO patients, as this reactive approach leads to poor glycemic control 4
- The American Diabetes Association recommends not discontinuing basal insulin completely when a patient becomes NPO; instead, reduce the dose to 60-80% of usual 4
- The American Diabetes Association recommends not extending monitoring intervals beyond 6 hours in NPO patients, even if glucose appears stable, as this increases risk of undetected hypoglycemia 1, 3